TY - JOUR
KW - CPRD Aurum
KW - Cprd gold
KW - clinical practice research datalink
KW - data quality
KW - Validation
KW - shares of Amgen Inc. Jick, Vasilakis-Scaramozza, Persson, and Hagberg are
KW - employees of Boston Collaborative Drug Surveillance program which receives
KW - industry funding to conduct research using CPRD data. The authors report no other
KW - conflicts of interest in this work.
AU - S. Jick
AU - C. Vasilakis-Scaramozza
AU - R. Persson
AU - D. Neasham
AU - G. Kafatos
AU - K. Hagberg
AD - Epidemiology, Boston Collaborative Drug Surveillance Program, Lexington, MA, USA.
Epidemiology, Boston University School of Public Health, Boston, MA, USA.
Center for Observational Research, Amgen Ltd, Uxbridge, UK.
AN - 38126004
BT - Clin Epidemiol
C2 - PMC10732313
DO - 10.2147/clep.s434832
DP - NLM
ET - 2023/12/21
LA - eng
N1 - 1179-1349
Jick, Susan
Orcid: 0000-0002-2215-1067
Vasilakis-Scaramozza, Catherine
Orcid: 0000-0002-8721-4604
Persson, Rebecca
Orcid: 0000-0003-2979-3238
Neasham, David
Kafatos, George
Orcid: 0000-0001-7871-9216
Hagberg, Katrina Wilcox
Orcid: 0000-0002-2407-2995
Journal Article
New Zealand
Clin Epidemiol. 2023 Dec 16;15:1219-1222. doi: 10.2147/CLEP.S434832. eCollection 2023.
PY - 2023
SN - 1179-1349 (Print)
1179-1349
SP - 1219
EP - 1222
T2 - Clin Epidemiol
TI - Use of the CPRD Aurum Database: Insights Gained from New Data Quality Assessments
VL - 15
ER -